🧠 Watchlist Winners: Copy Legendary Investors' Portfolios in One ClickCOPY FOR FREE

Biomerieux SA (BIOX)

Paris
Currency in EUR
Disclaimer
110.10
-0.10(-0.09%)
Closed
BIOX Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
Fair Value
Day's Range
109.60111.10
52 wk Range
84.54111.50
Prev. Close
110.1
Open
110.5
Day's Range
109.6-111.1
52 wk Range
84.54-111.5
Volume
99,060
Average Volume (3m)
85,260
1-Year Change
19.8%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
BIOX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
116.28
Upside
+5.61%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple
Show more

Biomerieux SA Company Profile

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries. It also provides a suite of software products and services that collect, analyze, and merge various sources of data to make decisions under the BIOMÉRIEUX VISION SUITE name; designs, manufactures, and maintains instruments and software; and designs and manufactures reagents for in vitro diagnostic tests. The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

Employees
13696
Market
France

Compare BIOX to Peers and Sector

Metrics to compare
BIOX
Peers
Sector
Relationship
P/E Ratio
31.6x22.8x−0.6x
PEG Ratio
4.680.290.00
Price/Book
3.4x2.4x2.6x
Price / LTM Sales
3.4x3.1x3.1x
Upside (Analyst Target)
9.0%17.5%55.8%
Fair Value Upside
Unlock−0.7%7.3%Unlock

FAQ

What Is the Biomerieux (BIOX) Stock Price Today?

The Biomerieux stock price today is 110.10

What Stock Exchange Does Biomerieux Trade On?

Biomerieux is listed and trades on the Paris stock exchange.

What Is the Stock Symbol for Biomerieux?

The stock symbol for Biomerieux is "BIOX."

Does Biomerieux Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 0.77%.

What Is the Biomerieux Market Cap?

As of today, Biomerieux market cap is 12.99B.

What is Biomerieux Earnings Per Share?

The Biomerieux EPS is 3.49.

What Is the Next Biomerieux Earnings Date?

Biomerieux will release its next earnings report on 29 Oct 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.